Evidence map›Paper›PMID 42305111›Full record

ArticleSynthetic and systems biotechnology2026

A cell-free system for 1,6-hexanediamine synthesis using bulk chemical caprolactam as the feedstock.

Ren Liu, Chouqiang Li, Yihui Zhang, Guohui Li, Yu Deng

Abstract read
In one paragraph

Article in Synthetic and systems biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ren LiuSchool of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.
Chouqiang LiSchool of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.
Yihui ZhangSchool of Science/Applied Chemistry, Xi'an Jiaotong Liverpool University, 111 Ren'ai Road, Suzhou, Jiangsu, 215123, China.
Guohui LiSchool of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.
Yu DengSchool of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu, 214122, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomanufacturing, with its advantages of mildness, low carbon emissions, and renewability, drives the frontier of green chemistry and sustainable development. However, complex metabolic pathways and intracellular resource competition frequently limit the efficiency and yield of metabolic engineering approaches, particularly for non-natural compounds such as 1,6-hexanediamine (1,6-HMD), an important precursor for nylon 66. To address these challenges, we developed a cell-free biocatalytic system employing 6-aminocaproic acid (6-ACA), derived from low-cost caprolactam, together with optimized enzyme assembly and cofactor regeneration. As a result, the 1,6-hexanediamine titer was enhanced by 511-fold, reaching a record-high level of 10.35 g/L with a conversion rate of 97.4%. The system was further extended to the production of C7-C10 α,ω-diamines, achieving high-level titers. In addition, the cell-free biocatalytic system retained considerable activity after 7 days of storage at 4 °C, with a 25.9% reduction in titer. This cell-free biocatalysis overcame the inherent limitations of biological systems and preserved enzyme activity, demonstrating the substantial potential for efficient diamine synthesis and indicating broad applicability for future practical implementations.

Indexed as

1,6-HexanediamineBiomanufacturingCell-free catalytic systemEnzyme compatibilityα,ω-diamines

Identifiers

PMID42305111
PMCPMC13266219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.